Relative Developmental Toxicities of Acrylates in Rats following Inhalation Exposure
|
|
- Polly Jody Preston
- 5 years ago
- Views:
Transcription
1 TOXICOLOGICAL SCIENCES 48, (1999) Copyright 1999 by the Society of Toxicology Relative Developmental Toxicities of Acrylates in Rats following Inhalation Exposure A. M. Saillenfait, 1 P. Bonnet, F. Gallissot, J. C. Protois, A. Peltier, and J. F. Fabriès Institut National de Recherche et de Sécurité, Vandoeuvre, France Received May 31, 1998; accepted August 24, 1998 The developmental toxicities of seven acrylates were studied in Sprague-Dawley rats after inhalation exposure for 6 h/day, during days 6 to 20 of gestation. The exposure concentrations were: for acrylic acid, 50, 100, 200, or 300 ppm; for methyl acrylate, 25, 50, or 100 ppm; for ethyl acrylate, 25, 50, 100, or 200 ppm; for butyl acrylate, 100, 200, or 300 ppm; for ethylhexyl acrylate, 50, 75, or 100 ppm; for hydroxyethyl acrylate, 1, 5, or 10 ppm; and for hydroxypropyl acrylate, 1, 5, or 10 ppm. No treatment-related increases in embryo/fetal mortality or fetal malformations were observed after exposure to any of these acrylates. Fetal toxicity, indicated by reduced fetal body weight, was observed after exposure to 300 ppm acrylic acid, 100 ppm methyl acrylate, 200 ppm ethyl acrylate, and 200 or 300 ppm butyl acrylate in the presence of overt signs of maternal toxicity. While there was evidence of maternal toxicity, no significant developmental toxic effects were observed after exposure to ethylhexyl acrylate, hydroxyethyl acrylate, or hydroxypropyl acrylate at any concentration. These results indicate that inhaled acrylic acid, methyl acrylate, ethyl acrylate, butyl acrylate, ethylhexyl acrylate, hydroxyethyl acrylate, and hydroxypropyl acrylate are not selectively toxic to the embryo or fetus. Key Words: acrylates; inhalation exposure; developmental toxicity; rat. Acrylic acid esters are high-volume chemicals used in the manufacture of thermoplastics, acrylic resins, and emulsion polymers. They are also used as plasticizers, latex coating, adhesives, fibers, floor finishers, and lubricant additives (Bisesi, 1994). The production of acrylic ester monomers in the U.S. was approximately 450,000 tons in 1989 (Novak, 1991). This represented about 45% of the worldwide production. Published reports on the developmental toxicity of basic acrylic esters are few. When ethyl acrylate was administered by gavage to groups of 10 to 23 Wistar rats at doses of 25, 50, 100, 200, or 400 mg/kg/day from day 7 to 16 of gestation (day 1 of gestation being the day of insemination), maternal body weight was reduced in all treated groups. The total number of resorptions was significantly increased at the three highest doses, but the average number of live fetuses per litter was not 1 To whom correspondence should be addressed. Fax: E- mail: saillenfait@inrs.fr. significantly affected. Skeletal examination of about half of the fetuses revealed an increase in the overall incidence of skeletal defects (delayed ossification of sternebrae, skull anomalies, lack of ribs or shortened ribs) in all the treated groups. Soft tissues were not examined (Pietrowicz et al., 1980). Murray et al. (1981) exposed time-pregnant Sprague-Dawley rats to concentrations of 50 or 150 ppm ethyl acrylate for 6 h/day on days 6 15 of gestation. Maternal effects, evidenced by reduced body weight gain and food consumption and increased water consumption were observed at 150 ppm. There were no statistically significant increases in the incidences of individual or total malformations, although multiple malformations including hypoplastic tail were observed in only three fetuses from three different litters at 150 ppm, among the 338 fetuses from 29 litters examined. Butyl acrylate was administered by inhalation to Sprague-Dawley rats, 6 h/day, from day 6 to 15 of gestation at 25, 135, or 250 ppm (Merkle and Klimisch, 1983). Maternal toxicity, expressed by a decrease in body weight gain, occurred at 135 and 250 ppm. No evidence of teratogenic effects was found. There was a concentration-related decrease in the numbers of live fetuses per litter, but these differences were not statistically significant. The percentage of resorptions was also significantly increased at 135 and 250 ppm. Thus, only ethyl acrylate and butyl acrylate have been studied, and definite conclusions regarding their developmental toxicity potential are difficult to draw from the limited and somewhat divergent data available. This study was undertaken to provide further information on the developmental toxicity of six acrylic esters, in rats, after inhalation exposure throughout the embryonic and fetal periods. The test compounds included methyl acrylate, ethyl acrylate, butyl acrylate, ethylhexyl acrylate, hydroxyethyl acrylate, and hydroxypropyl acrylate. Acrylic acid was also included for comparative purposes. MATERIALS AND METHODS Chemicals. Acrylic acid (99 % pure), methyl acrylate (99 % pure), and ethyl acrylate (99 % pure) were obtained from Fluka Chemie AG (Buchs, Switzerland). n-butyl acrylate (99 % pure) was obtained from Aldrich Chemical Co. (Milwaukee, WI). 2-Hydroxyethyl acrylate (95.8% pure, GC) and hydroxypropyl acrylate (97.5% pure, GC, mixture of isomers) were a gift from 240
2 ACRYLATES EMBRYOTOXICITY 241 Röhm (Germany). 2-Ethylhexyl acrylate (99.7% pure, GC) was a gift from Elf Atochem (France). Animals. After two weeks of acclimatization, nulliparous female ( g) Sprague-Dawley rats supplied by IFFA CREDO Breeding Laboratories (Saint-Germain-sur-l Arbresle, France) were housed overnight with adult males (one male:two or three females) from the same strain and supplier. The day that vaginal smears were found to be sperm-positive was considered day 0 of gestation (GD). Mated females were randomly assigned to treatment groups using a randomization system stratified by body weight on GD 0. Mated females were singly housed in clear polycarbonate cages with stainless-steel wire lids and hardwood shavings as bedding in rooms maintained at 21 2 C, a relative humidity of 50 5%, and a 12-h light-dark photocycle. For exposures, the females were transferred to stainless-steel wire mesh exposure cages, and the cages were moved into the chambers. After each exposure, the animals returned to their original cages and home rooms. Food pellets (UAR Alimentation Villemoisson, France) and filtered tap water were available ad libitum, except during exposures. Experimental design. Each of the above chemicals was tested in a separate experiment, following the same general protocol: groups of bred female rats (17 25 pregnant) were exposed to the compound 6 h/day on days 6 through 20 of gestation. The concentrations of acrylic acid were 50, 100, 200, and 300 ppm; of methyl acrylate, 25, 50, and 100 ppm; of ethyl acrylate, 25, 50, 100, and 200 ppm; of butyl acrylate, 100, 200, and 300 ppm; of ethylhexyl acrylate, 50, 75, and 100 ppm; of hydroxyethyl acrylate, 1, 5, and 10 ppm; and of hydroxypropyl acrylate, 1, 5, and 10 ppm. Control animals were exposed concurrently to filtered room air in an adjacent chamber with characteristics identical to those of the treatment groups. Exposure concentrations were based on preliminary studies in which severe maternal toxicity (i.e., weight loss during GD 6-13 and pronounced reduction in weight gain during GD 13-21) was observed at 200 ppm methyl acrylate, 25 ppm hydroxyethyl acrylate, and 25 ppm hydroxypropyl acrylate. Maternal mortality also occurred at 200 ppm methyl acrylate and 25 ppm hydroxyethyl acrylate. Selection of ethyl- and butyl-exposure levels was based, in part, on preliminary experiments in which marked decreases in maternal weight gain were observed at 200 and 300 ppm of ethyl and butyl acrylate. Results from previous prenatal inhalation toxicity studies on ethyl and butyl acrylate were also considered (Murray et al., 1981; Merkle and Klimisch, 1983). The high concentrations of ethyl and butyl acrylate for the definitive study (200 and 300 ppm, respectively) were chosen to maximize the opportunity of identifying embryolethal or teratogenic potential. Only minimal maternal toxicity was observed after exposure to 90 ppm ethylhexyl acrylate. Nevertheless, 100 ppm ethylhexyl acrylate was used as the highest concentration for the definitive developmental toxicity study, since preliminary level-setting studies have indicated that 100 ppm was the highest reliable vapor concentration technically possible. Generation of test atmospheres. Exposures were conducted in 200-L glass/stainless-steel inhalation chambers with dynamic and adjustable laminar air flow (6 20 m 3 /h). In order to prevent any leakage of the test atmospheres, the chambers were maintained at a negative pressure of no more than 3 mm water. The chamber temperature was set at 23 2 C, and the relative humidity at 50 5%. Food and water were withheld during exposure. Two vaporgeneration systems were used depending on the chemical tested. The first system, used for acrylic acid, 2 hydroxyethyl acrylate, and hydroxypropyl acrylate, delivered, with an infusion pump, a constant rate of liquid chemical from the top of a heated glass column filled with glass beads. Compressed air heated by a glass heater was introduced at the bottom of the glass column in a countercurrent fashion to the liquid flow. In the second system, used for methyl acrylate, ethyl acrylate, n-butyl acrylate, and 2-ethylhexyl acrylate, an additional air-flow rate passed through the fritted disk of a heated bubbler containing the test chemical. In both systems, the vaporized compounds were introduced into the main air inlet pipe of the exposure chambers. Atmosphere sampling and analysis. Concentrations of acrylate esters were monitored continuously with a gas-chromatograph equipped with a flame ionization detector and an automatic gas-sampling valve. In addition, exposure Compound TABLE 1 Mean Analytical Concentrations of Compounds in Exposure Chambers Target concentrations (ppm) Analytical concentrations (ppm) Mean S.D. Low Range High Acrylic acid Methyl acrylate Ethyl acrylate Hydroxyethyl acrylate n-butyl acrylate Hydroxypropyl acrylate Ethylhexyl acrylate levels were determined once during each 6-h exposure period by collecting atmosphere samples through glass tubes packed with activated charcoal. The charcoal samples were then desorbed with carbon disulfide, except for the 2-hydroxyethyl acrylate and 2-hydroxypropyl acrylate samples, which were desorbed with dichloromethane. The resulting samples were then analyzed by gas chromatography using appropriate internal standards. Internal calibrations of acrylates were performed using isobutyl acetate, n-butyl acetate, hydroxypropyl acrylate, n-hexyl acetate, 2-hydroxyethyl acrylate and 5-nonanone, for methyl acrylate, ethyl acrylate, 2-hydroxyethyl acrylate, n-butyl acrylate, hydroxypropyl acrylate, and 2-ethylhexyl acrylate analyses, respectively. Concentrations of acrylic acid were determined 3 times, at regular intervals, during each 6-h exposure period. Atmosphere samples were collected through quartz fiber filters impregnated with a Na 2 CO 3 and glycerol solution. The filters were then desorbed with deionized water. The resulting samples were analyzed by a Dionex ion chromatograph equipped with AG9-SC and AS9-SC columns. Concentrations of acrylic acid were not monitored continuously. Because the concentrations determined by analyses were essentially the same as the target concentrations, the target concentrations will be referred to throughout this paper (Table 1). In the case of acrylic acid, hydroxyethyl acrylate, hydroxypropyl acrylate, and ethylhexyl acrylate, which have low vapor pressures (3.2, 0.07, 0.07,
3 242 SAILLENFAIT ET AL. and 0.14 mmhg at 20 C, respectively), the presence of liquid particles was evaluated at the highest concentration generated (i.e., 300, 25, 25, and 100 ppm, respectively). Airborn particles were measured with an Aerodynamic Particle Sizer (APS 3300 model, TSI, USA), with a minimum detection limit of 0.5 m. No differences in particle counts were observed between the clean filtered air (control) and the vapor-laden air in the exposure chambers. Maternal and fetal evaluations. Food consumption was measured for the intervals GD 6-13 and Maternal body weights were recorded on GD 0, 6, 13, and 21. On GD 21, the females were euthanized with an intrapulmonary injection of T61 (Hoechst, Frankfurt, Germany) and the uteri were removed and weighed. The number of implantation sites, resorptions, and dead and live fetuses were recorded. Uteri which had no visible implantation sites were stained with ammonium sulfide (10%) to detect very early resorptions (Salewski, 1964). Live fetuses were weighed, sexed, and examined for external anomalies including those of the oral cavity. Half of the live fetuses from each litter were preserved in Bouin s solution and examined for internal soft tissue changes (Barrow and Taylor, 1969; Wilson, 1965). The other half were fixed in ethanol (70%), eviscerated, and then processed for skeletal staining with alizarin red S for subsequent skeletal examination (Staples and Schnell, 1964). Statistical analysis. Whenever possible, the data were presented as mean SD. The number of implantation sites and live fetuses and the various body weights were analyzed by one-way analysis of variance (ANOVA), followed by Dunnett s test if differences were found. The percentages of non-live implants and resorptions and the proportions of fetuses with alterations in each litter were evaluated by using the Kruskal-Wallis test, followed by the Dixon-Massey test where appropriate. Rates of pregnancy, fetal sex ratio, and percentages of litters with malformations or external, visceral, or skeletal variations were analyzed by using Fisher s test. Where applicable, least-squares analysis was carried out. For all statistical tests, the level of significance was set a priori at Acrylic Acid RESULTS All the animals survived this exposure. Maternal body weight gain was significantly reduced during the first half of exposure at 200 ppm, and thoughout the whole exposure period at 300 ppm (Table 2). Absolute weight gain was significantly reduced at 200 and 300 ppm. A decrease in maternal food intake was observed during the first half of exposure at 50 and 100 ppm (8% less than control), and throughout exposure at higher concentrations (Table 3). The mean numbers of implantation sites and of live fetuses and the incidence of non-live implants and resorptions were comparable across groups (Table 4). Acrylic acid induced a concentration-related decrease in fetal body weights that were significantly different from those of control at 300 ppm (9% lower than control). Several external and visceral malformations were observed sporadically with no indication of an adverse effect related to exposure (Table 5). The occurrences of fetuses with external or skeletal variations did not differ between control and acrylic acidtreated groups. A significant increase in the percentage of litters with visceral variations was observed at the low concentration, together with an increased incidence of distended ureter, a common variant in rat fetuses. In contrast, the mean percentage of fetuses with any variations per litter was significantly lower at the highest concentration. These findings appeared to be random and to have no biological significance related to acrylic-acid exposure. Methyl Acrylate Exposure to methyl acrylate up to 100 ppm did not cause maternal death. Significant decreases in maternal weight gain and in food consumption were observed at 50 and 100 ppm during the entire exposure period (Tables 2 and 3). Exposure to 50 or 100 ppm was associated with maternal weight loss when gravid uterus weights were substracted from the body weight gains. No significant effect on the implantation sites, live fetuses, incidence of non-live implants and resorptions, or on fetal sex ratio was discerned in any of the groups exposed to methyl acrylate (Table 4). Methyl acrylate induced a concentrationrelated decrease in fetal body weights that achieved significance at 100 ppm (17% lower than control). A single case of malformation was observed at 100 ppm (Table 6). There were no statistically significant increases in the incidences of external, visceral, or skeletal variations in any treatment group relative to controls. Ethyl Acrylate No maternal deaths were observed during this study. Exposure to 200 ppm led to significant decreases in maternal body weight gain throughout exposure and in absolute weight gain (Table 2). No data on food consumption are available because of a technical failure. There was no significant difference in the numbers of implantation sites and live fetuses, in the incidence of non-live implants and resorptions, or in the fetal sex ratio (Table 4). Fetal body weights were significantly reduced at 200 ppm (7 8% lower than control, p 0.01). Single occurrences of visceral malformations were seen in control and in the 50 and 200 ppm-treated groups (Table 7). The incidences of external, visceral, and skeletal variations were scattered, with no indication of adverse effects in any of the exposed groups when compared to the controls. Butyl Acrylate All female rats survived the test period. For the entire exposure period, maternal weight gains were markedly lower in the 200- and 300-ppm groups than in the control group, with body weight loss occurring at 300 ppm between GD 6 and GD 13 (Table 2). Absolute weight gains were depressed in a concentration-related manner at all exposure levels. Food consumption was significantly reduced during the first half of the exposure at 100 ppm and throughout the exposure period at 200 and 300 ppm (Table 3). The maximum decrease was 40 50% at the highest concentration. No adverse effects on the numbers of implantation sites and live fetuses, or the incidence of non-live implants and resorp-
4 ACRYLATES EMBRYOTOXICITY 243 TABLE 2 Change in Weight During Gestation in Sprague-Dawley Rats Inhaling Acrylic Acid, Methyl Acrylate, Ethyl Acrylate, Butyl Acrylate, Ethylhexyl Acrylate, Hydroxyethyl Acrylate, or Hydroxypropyl Acrylate on Days 6 to 20 of Gestation a Compound Concentration ppm/6 h/day No. of dams Body weight (g) on GD6 Body weight gain (g) on GD Absolute weight gain (g) b Acrylic acid c ** ** 5 12** ** 75 15** 88 18** 13 14** Methyl acrylate ** 73 20** 90 25** 8 21** ** 47 38** 51 48** 40 36** Ethyl acrylate ** 70 15** 87 21** 17 16** Butyl acrylate * ** 76 26** 84 34** 16 20** ** 27 24** 18 34** 60 26** Ethylhexyl acrylate ** Hydroxyethyl acrylate * ** Hydroxypropyl Acrylate * * ** a Includes all dams pregnant at euthanization. b (Day 21 body weight) (gravid uterus weight) (Day 6 body weight). c Values are expressed as means SD. *,** Significant differences from the control (0 ppm) value, p 0.05, and p 0.01, respectively. tions were noted among litters exposed to butyl acrylate (Table 4). Fetal body weight was significantly reduced at 200 ppm (all and males) and at 300 ppm (all, males, females). These decreases amounted to 7 8% and 26 28% of the control values at 200 ppm and 300 ppm, respectively. Few sporadic malformations were seen in the control and 300 ppm groups (Table 8). There was no evidence of treatment-related effects on the incidence of external and visceral variations. The incidence of individual skeletal variations (mainly incomplete ossification of sternebrae and of vertebral centra) was similar in the control and treated groups. Ethylhexyl Acrylate No test dams died. Except for a significant decrease in absolute weight gain at 100 ppm, there were no significant changes in maternal weight gain of females exposed to ethylhexyl acrylate, compared to those of controls (Table 2). Rats from the 100-ppm group showed a significant decrease in food intake throughout the entire exposure period (8 11% reduction) (Table 3). No adverse effects were observed on the mean number of implantations and live fetuses among litters exposed to ethyl-
5 244 SAILLENFAIT ET AL. TABLE 3 Food Consumption of Sprague-Dawley Rats Inhaling Acrylic Acid, Methyl Acrylate, Butyl Acrylate, Ethylhexyl Acrylate, Hydroxyethyl Acrylate, or Hydroxypropyl Acrylate on Days 6 to 20 of Gestation a Compound Concentration ppm/6 h/day No. dams Food consumption (g/dam/day) on GD Acrylic acid b c d c d 23 2 d 21 1 d d 20 2 d 19 2 d Methyl acrylate d 20 3 d 20 3 d c 16 2 d 16 6 d 16 4 d Butyl acrylate c c d 23 3 d 21 3 d d 15 4 d 16 4 d Ethylhexyl acrylate d 26 3 d 24 3 d Hydroxyethyl acrylate d 25 2 d 23 2 d Hydroxypropyl acrylate c 24 2 c 22 2 c a Includes all dams pregnant at euthanization. b Values are expressed as means SD. c,d Denote significant differences from the control (0 ppm) value, p 0.05 and p 0.01, respectively. hexyl acrylate (Table 4). The statistically significant reductions in the incidence of non-live implants and resorptions at 50 and 100 ppm were not considered to be of toxicological significance. There was a statistically significant trend toward decreased fetal body weights (p 0.05), but the pairwise comparisons to the concurrent control group were not significantly different. No significant differences were observed between control and treated groups in the incidence of fetal malformations or variations (Table 9). Hydroxyethyl Acrylate No test dams died. Maternal body weight gain during GD 6-13 and absolute weight gain were significantly reduced at 10 ppm (Table 2). A slight but statistically significant decrease in maternal food consumption was seen at 10 ppm for the entire exposure period (Table 3). There were no significant changes in the numbers of implantations and live fetuses, incidence of non-live implants and resorptions, or fetal body weights across groups (Table 4). The only malformation observed was a unilateral microphthalmia at 1 ppm (Table 10). There were no significant changes in the incidence of external, visceral, or skeletal variations. Hydroxypropyl Acrylate No maternal deaths were observed. Maternal weight gain was significantly less than control during the first half of exposure at 10 ppm and absolute weight gain at 5 and 10 ppm. Food consumption was slightly reduced during treatment at 10 ppm. The number of implantation sites and live fetuses, and the incidence of non-live implants and resorptions were comparable among groups (Table 4). There was no effect on fetal
6 TABLE 4 Reproductive Parameters in Sprague-Dawley Rats Inhaling Acrylic Acid, Methyl Acrylate, Ethyl Acrylate, Butyl Acrylate, Ethylhexyl acrylate, Hydroxyethyl Acrylate, or Hydroxypropyl Acrylate on Days 6 to 20 of Gestation Litters with implants Litters with live fetuses Compound Concentration ppm/6 h/day No. Females on study No. of litters No. of implantation sites per litter % of nonlive implants per litter a %of resorption sites per litter No. of litters No. of live fetuses per litter Fetal sex ratio M:F Average fetal body weight (g) per litter All Males Females Acrylic acid b c c c d d d Methyl acrylate d d d Ethyl acrylate d d d Butyl acrylate c c d d d Ethylhexyl acrylate c c c c Hydroxyethyl acrylate Hydroxypropyl acrylate ACRYLATES EMBRYOTOXICITY a Resorptions plus dead fetuses. b Values are expressed as means SD. c,d Denote significant differences from the control (0 ppm) value, p 0.05 and p 0.01, respectively. 245
7 246 SAILLENFAIT ET AL. TABLE 5 Incidence of Malformations and Variations in Fetuses of Sprague-Dawley Rats Inhaling Acrylic Acid on Days 6 to 20 of Gestation a Concentration (ppm/6 h/day) Total No. fetuses (litters) examined External 330 (23) 271 (20) 307 (22) 290 (21) 337 (23) Visceral 165 (23) 135 (20) 154 (22) 145 (21) 169 (23) Skeletal 165 (23) 136 (20) 153 (22) 145 (21) 168 (23) Malformations b Anasarca (1) 0 Hydrocephaly 1 (1) Microphthalmia (unilateral) (1) 0 Omphalocele 1 (1) (1) 0 Interventricular septum defect 1 (1) Ectopic testis (bilateral) 1 (1) Anal atresia 1 (1) (1) 0 No. (%) fetuses with any malformations 2 (0.6) (1.0) 0 No. (%) litters with any malformations 2 (8.7) (14.3) 0 Mean % fetuses with any malformations per litter c External variations Club foot 0 1 (1) No. (%) fetuses with external variations 0 1 (0.4) No. (%) litters with external variations 0 1 (5.0) Mean % fetuses with external variations per litter Visceral variations Dilated renal pelvis 1 (1) 1 (1) 1 (1) 1 (1) 0 Distended ureter 19 (8) 30 (14) f 16 (11) 15 (8) 4 (3) No. (%) fetuses with visceral variations 19 (11.5) 30 (22.2) 16 (10.4) 16 (11.0) 4 (2.4) No. (%) litters with visceral variations 8 (34.8) 14 (70.0) e 11 (50.0) 8 (38.1) 3 (13.0) Mean % fetuses with visceral variations per litter f Skeletal variations Skull Parietals, incomplete ossification, slight (1) 0 Hyoid, incomplete ossification or unossified d 3 (2) 0 1 (1) 0 0 5th and/or 6th sternebrae, incomplete ossification or unossified 8 (7) 8 (5) 6 (5) 3 (2) 6 (6) Rib(s) Floating (1) Cervical, rudimentary 3 (3) 6 (3) 0 2 (2) 1 (1) 14th, supernumerary 10 (7) 3 (2) 10 (8) 4 (4) 9 (6) Thoracic vertebral centra, incomplete ossification (one or two) 10 (8) 10 (7) 5 (5) 9 (5) 7 (6) No. (%) fetuses with skeletal variations 32 (19.4) 25 (18.4) 23 (15.0) 19 (13.1) 23 (13.7) No. (%) litters with skeletal variations 19 (82.6) 12 (60.0) 14 (63.6) 12 (57.1) 13 (56.5) Mean % fetuses with skeletal variations per litter No. (%) fetuses with any variations 51 (15.4) 56 (20.7) 39 (12.7) 35 (12.1) 27 (8.0) No. (%) litters with any variations 20 (87.0) 20 (100.0) 20 (90.9) 16 (76.2) 14 (60.9) Mean % fetuses with any variations per litter f a The incidence of individual defect is presented as number of fetuses (number of litters). Only live fetuses were examined. A single fetus may be represented more than once in listing individual defects. b One fetus in the control group (air) had hydrocephaly, protruding tongue, interventricular septum defect, ectopic testis, and anal atresia. One fetus in the 200 ppm group had anasarca and anal atresia. c Mean SD. d Unossified: alizarine red S negative. e p 0.05, Fisher s test. f p 0.05, Dixon-Massey s test.
8 ACRYLATES EMBRYOTOXICITY 247 TABLE 6 Incidence of Malformations and Variations in Fetuses of Sprague-Dawley Rats Inhalating Methyl Acrylate on Days 6 to 20 of Gestation a Concentration (ppm/6 h/day) Total No. fetuses (litters) examined External 324 (25) 305 (21) 323 (23) 336 (23) Visceral 162 (25) 153 (21) 162 (23) 168 (23) Squelettal 162 (25) 152 (21) 161(23) 168 (23) Malformations b Craniorachischisis (1) Multiple skeletal malformations (1) No. (%) fetuses with any malformations (0.3) No. (%) litters with any malformations (4.3) Mean % fetuses with any malformations per litter c External variations Club foot (unilateral) 1 (1) No. (%) fetuses with external variations 1 (0.3) No. (%) litters with external variations 1 (4.0) Mean % fetuses with external variations per litter Visceral variations Ovary, displaced (1) Dilated renal pelvis 0 1 (1) 0 0 Distended ureter 10 (4) 8 (4) 4 (4) 6 (2) No. (%) fetuses with visceral variations 10 (6.2) 8 (5.2) 4 (2.5) 7 (4.2) No. (%) litters with visceral variations 4 (16.0) 4 (19.0) 4 (17.4) 3 (13.0) Mean % fetuses with visceral variations per litter Skeletal variations Hyoid, incomplete ossification 0 1 (1) 0 2 (2) 5 and/or 6th sternebra(e), incomplete ossification or unossified d 6 (5) 4 (2) 5 (4) 17 (5) Rib(s) Cervical, rudimentary 3 (1) 7 (5) 3 (3) 1 (1) 14th, supernumerary 11 (6) 9 (6) 11 (7) 9 (7) 13th, short (1) Thoracic vertebral centra, incomplete ossification (one or two) 11 (7) 5 (4) 6 (4) 6 (4) No. (%) fetuses with skeletal variations 29 (17.9) 24 (15.8) 25 (15.5) 32 (19.0) No. (%) litters with skeletal variations 15 (60.0) 12 (57.1) 13 (56.5) 15 (65.2) Mean % fetuses with skeletal variations per litter No. (%) fetuses with any variations 40 (12.3) 32 (10.5) 29 (9.0) 39 (11.6) No. (%) litters with any variations 16 (64.0) 13 (61.9) 16 (69.6) 17 (73.9) Mean % fetuses with any variations per litter a The incidence of individual defect is presented as number of fetuses (number of litters). Only live fetuses were examined. A single fetus may be represented more than once in listing individual defects. b One fetus in the 100 ppm group had craniorachischisis, protruding tongue, and multiple skull and vertebral alterations including fused thoracic vertebral arches, thoracic hemicentrae, bilobed thoracic and lumbar vertebral centrae, and fused vertebral centrea and archs in the caudal and sacral regions. c Mean SD. d Unossified: alizarine red S negative. weights at any exposure level. Visceral malformations were observed in single fetuses in the control and the 5 ppm groups (Table 11). Several visceral and skeletal variations were observed, with no significant differences between treated and control groups. DISCUSSION Acrylic acid and six of its esters were assessed for their prenatal inhalation toxicity in rats. Exposure to 200 or 300 ppm acrylic acid caused obvious maternal toxicity with significant decreases in body weight gain and food consumption throughout the exposure period. At 50 and 100 ppm acrylic acid exposure, a decrease in food consumption was observed only during the first half of exposure and was not accompanied by a significant decrease in body weight changes. Marked maternal toxicity was demonstrated at 50 and 100 ppm methyl acrylate, 200 ppm ethyl acrylate, and 200 and 300 ppm butyl acrylate. Thus, there were pronounced decreases in maternal
9 248 SAILLENFAIT ET AL. TABLE 7 Incidence of Malformations and Variations in Fetuses of Sprague-Dawley Rats Inhaling Ethyl Acrylate on Days 6 to 20 of Gestation a Concentration (ppm/6 hr/day) Total No. fetuses (litters) examined External 237 (17) 225 (17) 255 (19) 271 (19) 261 (17) Visceral 119 (17) 112 (17) 128 (19) 135 (19) 131 (17) Skeletal 118 (17) 113 (17) 127 (19) 136 (19) 130 (17) Malformations b Retina, folded (1) Brain: lateral ventricle, blood filled (1) 0 0 Diaphragmatic hernia 1 (1) (1) No. (%) fetuses with any malformations 1 (0.4) 0 1 (0.4) 0 1 (0.4) No. (%) litters with any malformations 1 (5.9) 0 1 (5.3) 0 1 (5.9) Mean % fetuses with any malformations per litter c External variations Club foot (unilateral) (1) No. (%) fetuses with external variations (0.4) No. (%) litters with external variations (5.9) Mean % fetuses with external variations per litter Visceral variations Dilated renal pelvis 4 (2) (1) 1 (1) Distended ureter 4 (4) 8 (5) 11 (7) 8 (7) 2 (2) No. (%) fetuses with visceral variations 7 (5.9) 8 (7.1) 12 (9.4) 9 (6.7) 2 (1.5) No. (%) litters with visceral variations 5 (29.4) 5 (29.4) 8 (42.1) 8 (42.1) 2 (11.8) Mean % fetuses with visceral variations per litter Skeletal variations Skull Parietals, incomplete ossification, slight 1 (1) Supraoccipital, incomplete ossification, slight (1) 0 Hyoid, incomplete ossification or unossified d 2 (2) 6 (2) 2 (2) 0 0 Sternebra(e) Incomplete ossification or unossified 6 (6) 9 (7) 8 (6) 5 (5) 8 (6) 1st and 2nd, fused 0 1 (1) Rib(s) Cervical, rudimentary 2 (2) 2 (2) 1 (1) 2 (2) 2 (2) 14th, supernumerary 2 (2) 6 (2) 6 (5) 9 (7) 6 (5) Thoracic and/or lumbar vertebral centra, incomplete ossification (one to three) 8 (5) 8 (4) 8 (7) 7 (6) 15 (8) No. (%) fetuses with skeletal variations 19 (16.1) 27 (23.9) 23 (18.1) 22 (16.2) 27 (20.8) No. (%) litters with skeletal variations 11 (64.7) 11 (64.7) 11 (57.9) 13 (68.4) 13 (76.5) Mean % fetuses with skeletal variations per litter No. (%) fetuses with any variations 26 (11.0) 35 (15.6) 35 (13.7) 31 (11.4) 30 (11.5) No. (%) litters with any variations 13 (76.5) 12 (70.6) 15 (78.9) 16 (84.2) 14 (82.3) Mean % fetuses with any variations per litter a The incidence of individual defect is presented as number of fetuses (number of litters). Only live fetuses were examined. A single fetus may be represented more than once in listing individual defects. b One fetus in the 200 ppm group had folded retina, protruding tongue, and diaphragmatic hernia. c Mean SD. d Unossified: alizarine red S negative. body weight gain and food consumption over the entire exposure period. Less severe maternal toxicity was observed at 100 ppm butyl acrylate and was expressed as a transient decrease in food intake and a reduced absolute weight gain. Exposure to 100 ppm ethylhexyl acrylate resulted in maternal toxicity, evidenced by decreased absolute weight gain and food consumption during the period of treatment. This was the highest concentration possible without generating aerosol. Exposure to 10 ppm hydroxyethyl or hydroxypropyl acrylate caused overt maternal toxicity. This was evidenced by a transient decrease in body weight changes, a decrease in absolute weight gain, and a continuous reduction of food consumption during exposure. Maternal effects produced by 5 ppm hydroxypropyl acrylate were limited to a significant decrease in absolute weight gain. No evidence of teratogenic effects was found after exposure
10 ACRYLATES EMBRYOTOXICITY 249 TABLE 8 Incidence of Malformations and Variations in Fetuses of Sprague-Dawley Rats Inhaling Butyl Acrylate on Days 6 to 20 Gestation a Concentration (ppm/6 h/day) Total No. fetuses (litters) examined External 353 (25) 353 (24) 347 (24) 367 (25) Visceral 177 (25) 177 (24) 174 (24) 183 (24) Skeletal 176 (25) 176 (24) 173 (24) 183 (24) b Malformations c Anophthalmia (unilateral) 1 (1) Microphthalmia (unilateral) 1 (1) Palate, cleft 1 (1) Omphalocele 1 (1) Diaphragmatic hernia (1) Ectopic testis (bilateral) 1 (1) Sternum, entire unossified (1) Thoracic and lumbar vertebral centra unossified (1) No. (%) fetuses with any malformations 2 (0.6) (0.5) No. (%) litters with any malformations 2 (4.0) (4.0) Mean % fetuses with any malformations per litter d External variations Club foot 1 (1) (1) No. (%) fetuses with external variations 1 (0.3) (0.3) No. (%) litters with external variations 1 (4.0) (4) Mean % fetuses with external variations per litter Visceral variations Dilated renal pelvis 0 2 (2) 1 (1) 0 Distended ureter 16 (9) 11 (7) 6 (5) 1 (1) No. (%) fetuses with visceral variations 16 (9.0) 11 (6.2) 6 (3.4) 1 (0.6) No. (%) litters with visceral variations 9 (36.0) 7 (29.2) 5 (20.8) 1 (4.2) f Mean % fetuses with visceral variations per litter Skeletal variations Skull Supraoccipital, incomplete ossification (1) Hyoid, incomplete ossification 0 1 (1) 0 1 (1) 5 and/or 6th sternebra, incomplete ossification or unossified e 4 (4) 5 (5) 7 (7) 14 (8) Rib(s) Cervical, rudimentary 3 (3) 1 (1) 0 2 (2) 14th, supernumerary 4 (3) 6 (6) 13 (6) 9 (7) 13th, short (1) Floating 1 (1) Thoracic vertebral centra, incomplete ossification (one or two) 11 (9) 18 (12) 10 (8) 21 (11) No. (%) fetuses with skeletal variations 22 (12.5) 28 (15.9) 27 (15.6) 46 (25.1) No. (%) litters with skeletal variations 15 (60.0) 19 (79.2) 16 (66.7) 18 (75.0) Mean % fetuses with skeletal variations per litter No. (%) fetuses with any variations 39 (11.0) 39 (11.0) 33 (9.5) 48 (13.1) No. (%) litters with any variations 21 (84.0) 22 (91.7) 17 (70.8) 20 (80.0) Mean % fetuses with any variations per litter a The incidence of individual defect is presented as number of fetuses (number of litters). Only live fetuses were examined. A single fetus may be represented more than once in listing individual defects. b One fetus was inadvertently not examined skeletally, and therefore the N is reduced. c One fetus in the control group (air) had microphthalmia, cleft palate, and omphalocele. One fetus of another litter in the control group had anophthalmia, ectopic testis, and bilateral club foot. d Mean SD. e Unossified: alizarine red S negative. f p 0.05; Fisher s test.
11 250 SAILLENFAIT ET AL. TABLE 9 Incidence of Malformations and Variations in Fetuses of Sprague-Dawley Rats Inhaling Ethylhexyl Acrylate on Days 6 to 20 of Gestation a Concentration (ppm/6 h/day) Total No. fetuses (litters) examined External 355 (25) 357 (24) 351 (23) 352 (23) Visceral 178 (25) 179 (23) 175 (23) 176 (23) Skeletal 177 (25) 178 (24) 176 (23) 176 (23) Malformations b Head: tongue protruding and edema 0 1 (1) 0 0 Aorta, transposed 0 1 (1) 0 0 Diaphragmatic hernia 0 1 (1) 2 (2) 0 Hydronephrosis (unilateral) 1 (1) 2 (1) 1 (1) 0 No. (%) fetuses with any malformations 1 (0.3) 4 (1.1) 3 (0.8) 0 No. (%) litters with any malformations 1 (4.0) 3 (12.5) 3 (13.0) 0 Mean % fetuses with any malformations per litter c External variations Club foot (unilateral) 0 2 (2) 0 0 No. (%) fetuses with external variations 0 2 (0.6) 0 0 No. (%) litters with external variations 0 2 (8.33) 0 0 Mean % fetuses with external variations per litter Visceral variations Dilated renal pelvis 0 1 (1) 3 (3) 1 (1) Hydroureter (unilateral) (1) 0 Distended ureter 5 (4) 12 (8) 11 (8) 8 (5) No. (%) fetuses with visceral variations 5 (2.8) 11 (6.1) 14 (8.0) 8 (4.5) No. (%) litters with visceral variations 4 (16.0) 8 (34.8) 9 (39.1) 5 (21.7) Mean % fetuses with visceral variations per litter Variations Skull Parietals, incomplete ossification, slight 1 (1) (1) Interparietal, incomplete ossification, slight 0 1 (1) 0 0 Hyoid, incomplete ossification or unossified d 1 (1) 0 1 (1) 2 (2) Sternebrae, incomplete ossification or unossified 9 (6) 14 (7) 10 (4) 7 (7) Rib(s) Cervical, rudimentary 1 (1) 3 (1) 1 (1) 2 (2) 14th, supernumerary 14 (7) 12 (8) 13 (7) 9 (6) Thoracic vertebral centra, incomplete ossification (one or two) 11 (8) 16 (12) 14 (7) 9 (7) No. (%) fetuses with skeletal variations 36 (20.3) 40 (22.5) 35 (19.9) 28 (15.9) No. (%) litters with skeletal variations 17 (68.0) 19 (79.2) 12 (52.2) 17 (73.9) Mean % fetuses with skeletal variations per litter No. (%) fetuses with any variations 41 (11.5) 53 (14.8) 49 (14.0) 36 (10.2) No. (%) litters with any variations 19 (76.0) 22 (91.7) 16 (69.6) 18 (78.3) Mean % fetuses with any variations per litter a The incidence of individual defect is presented as number of fetuses (number of litters). Only live fetuses were examined. A single fetus may be represented more than once in listing individual defects. b One fetus in the 50 ppm group had head edema, protruding tongue, and transposed aorta. c Mean SD. d Unossified: alizarine red S negative. to any of the tested compounds, up to concentrations which were toxic to the mothers. Fetal toxicity was evident from the statistically significant decreases in the mean fetal body weight at 300 ppm acrylic acid, 100 ppm methyl acrylate, 200 ppm ethyl acrylate, and 200 and 300 ppm butyl acrylate. These effects occurred only in the highest-dose groups, where there was also marked maternal toxicity (i.e., severe decreases in maternal weights associated with reduced food consumption). Thus, the developmental toxicity observed here may be related to the altered maternal status. Although there was some evidence of maternal toxicity, no adverse developmental effects were noted at concentrations up to 100 ppm ethylhexyl acrylate, and 10 ppm hydroxyethyl or hydroxypropyl acrylate. Therefore, the no-observable-adverse-effect-level (NOAEL) for developmental toxicity was 200 ppm for acrylic acid, 50 ppm for methyl acrylate, 100 ppm
12 ACRYLATES EMBRYOTOXICITY 251 TABLE 10 Incidence of Malformations and Variations in Fetuses of Sprague-Dawley Rats Inhaling Hydroxyethyl Acrylate on Days 6 to 20 of Gestation a Concentration (ppm/6 h/day) Total No. fetuses (litters) examined External 274 (21) 263 (18) 304 (22) 301 (21) Visceral 137 (21) 132 (18) 152 (22) 150 (21) Skeletal 137 (21) 131 (18) 152 (22) 151 (21) Malformations b Microphthalmia (unilateral) 0 1 (1) 0 0 No. (%) fetuses with any malformations 0 1 (0.4) 0 0 No. (%) litters with any malformations 0 1 (5.5) 0 0 Mean % fetuses with any malformations per litter c 0 0 External variations Palate (rugae mishappen) 0 1 (1) 0 0 Club foot (unilateral) 1 (1) 0 1 (1) 2 (2) No. (%) fetuses with external variations 1 (0.4) 1 (0.4) 1 (0.3) 2 (0.7) No. (%) litters with external variations 1 (4.8) 1 (5.6) 1 (4.5) 2 (9.5) Mean % fetuses with external variations per litter Visceral variations Dilated renal pelvis (2) 0 Hydroureter (unilateral) (2) 0 Distended ureter 5 (3) 7 (5) 19 (8) 15 (6) No. (%) fetuses with visceral variations 5 (3.6) 7 (5.3) 19 (12.5) 15 (10.0) No. (%) litters with visceral variations 3 (14.3) 5 (27.8) 8 (36.4) 6 (28.6) Mean % fetuses with visceral variations per litter Skeletal variations Skull Parietals, incomplete ossification, slight (1) 0 Hyoid, incomplete ossification (2) 5th sternebra, incomplete ossification or unossified d 12 (8) 4 (3) 5 (4) 3 (3) Rib(s) Cervical, rudimentary 1 (1) 2 (2) th, supernumerary 7 (4) 6 (3) 16 (7) 6 (5) 13th, short 0 1 (1) 0 1 (1) Thoracic and/or lumbar vertebral centra, incomplete ossification (one to three) 10 (6) 12 (8) 18 (11) 12 (10) No. (%) fetuses with skeletal variations 28 (20.4) 23 (17.6) 38 (25.0) 22 (14.6) No. (%) litters with skeletal variations 11 (52.4) 12 (66.7) 16 (72.7) 13 (61.9) Mean % fetuses with skeletal variations per litter No. (%) fetuses with any variations 34 (12.4) 31 (11.8) 57 (18.7) 39 (13.0) No. (%) litters with any variations 13 (61.9) 13 (72.2) 17 (77.3) 16 (76.2) Mean % fetuses with any variations per litter a The incidence of individual defect is presented as number of fetuses (number of litters). Only live fetuses were examined. A single fetus may be represented more than once in listing individual defects. b One fetus in the 1 ppm group had microphthalmia and mishappen palate ruggae. c Mean SD. d Unossified: alizarine red S negative. for ethyl acrylate and butyl acrylate 100 ppm for ethylhexyl acrylate, and 10 ppm for hydroxyethyl and hydroxypropyl acrylate. Neeper-Bradley et al. (1997) reported no evidence of developmental toxicity in pregnant New Zealand White rabbits exposed to 25, 75, or 225 ppm acrylic acid on GD Klimisch and Hellwig (1991) exposed rats on GD 6 15 of gestation to acrylic acid at 40, 120, or 360 ppm. There were clear signs of maternal toxicity at 360 ppm. Body weight gain and food consumption were reduced
13 252 SAILLENFAIT ET AL. TABLE 11 Incidence of Malformations and Variations in Fetuses of Sprague-Dawley Rats Inhaling Hydroxypropyl Acrylate on Days 6 to 20 of Gestation a Concentration (ppm/6 h/day) Total No. fetuses (litters) examined External 286 (21) 260 (20) 294 (21) 285 (21) Visceral 143 (21) 130 (20) 147 (21) 143 (21) Skeletal 143 (21) 130 (20) 147 (21) 142 (21) Malformations Microphthalmia (bilateral) (1) 0 Diaphragmatic hernia 1 (1) No. (%) fetuses with any malformations 1 (0.3) 0 1 (0.3) 0 No. (%) litters with any malformations 1 (4.8) 0 1 (4.8) 0 Mean % fetuses with any malformations per litter b External variations No. (%) fetuses with external variations No. (%) litters with external variations Mean % fetuses with external variations per litter Visceral variations Subclavian branching variation 0 1 (1) 1 (1) 0 Dilated renal pelvis (2) 0 Distended ureter 5 (4) 8 (5) 10 (5) 7 (7) No. (%) fetuses with visceral variations 5 (3.5) 9 (6.9) 11 (7.5) 7 (4.9) No. (%) litters with visceral variations 4 (19.0) 6 (30.0) 6 (28.6) 7 (33.3) Mean % fetuses with visceral variations per litter Skeletal variations Sternebra(e) 5th incomplete ossification or unossified c 5 (4) 2 (2) 0 5 (4) 1st and 2nd, fused 0 1 (1) 0 0 Rib(s) Cervical, rudimentary 4 (4) 0 1 (1) 1 (1) 14th, supernumerary 4 (4) 11 (6) 18 (8) 4 (3) 11 and 12th, wavy (1) 0 Thoracic vertebral centra, incomplete ossification (one to three) 3 (3) 3 (2) 15 (8) 1 (1) No. (%) fetuses with skeletal variations 16 (11.2) 17 (13.1) 33 (22.4) 11 (7.7) No. (%) litters with skeletal variations 11 (52.4) 9 (45.0) 16 (76.2) 9 (42.9) Mean % fetuses with skeletal variations per litter No. (%) fetuses with any variations 21 (7.34) 26 (10.0) 44 (15.0) 18 (6.3) No. (%) litters with any variations 13 (61.9) 13 (65.0) 17 (80.9) 13 (61.9) Mean % fetuses with any variations per litter a The incidence of individual defect is presented as number of fetuses (number of litters). Only live fetuses were examined. A single fetus may be represented more than once in listing individual differences. b Mean SD. c Unossified, alizarine red S negative. throughout exposure at 360 ppm and at the beginning of the exposure period at 120 ppm. Indices of maternal toxicity were considered minimal at 40 ppm since only the absolute weight gain was significantly decreased. No adverse effects on fetal viability, morphology, or growth were observed at any concentration. In the current study, exposure to 50 ppm acrylic acid produced only slight maternal toxic effects, as indicated by the transient decrease in food consumption. Thus, the NOAEL is probably somewhat less than 50 ppm acrylic acid for the dams. Ethyl acrylate was administered by inhalation to pregnant Sprague-Dawley rats from GD6 to GD 15 at concentrations of 50 or 150 ppm (Murray et al., 1981). Maternal toxicity, expressed as decreased body weight gain, reduced food consumption, and increased water intake, was seen at 150 ppm. Growth and survival of the progeny was not affected. The incidences of individual or total anomalies were not significantly increased. However, three of the 29 litters exposed to 150 ppm ethyl acrylate produced three fetuses with multiple malformations, including hypoplastic tail. This alteration, which had been noted to occur among controls in past studies, was not considered as indicative of a
List by Region - Visceral Anomalies
1 List by Region - Visceral Anomalies General Terms 10127 Situs inversus 80,00 10125 Aneurysm 68,42 10126Fluid-filled abdomen -35,00 Brain 10131 Hydrocephaly 10128 Dilated cerebral ventricle 20,00 10132
More informationList by Terms Visceral anomalies
1 List by Terms Visceral anomalies Dilated 10128 Dilated cerebral ventricle 11 7 2 0 20,00 10201 Dilated aorta 9 8 2 1 5,26 10207 Dilated aortic arch 9 8 3 0 5,00 10213 Dilated carotid 3 12 4 1-47,37 10218
More informationEmbryo-Fetal Developmental Toxicity Studies with Pregabalin in Mice and Rabbits
C 2016 Wiley Periodicals, Inc. Birth Defects Research (Part B) 107:85 93 (2016) Original Article Embryo-Fetal Developmental Toxicity Studies with Pregabalin in Mice and Rabbits Dennis C. Morse Pfizer Worldwide
More informationFENPYROXIMATE (addendum) First draft prepared by T.C. Marrs Food Standards Agency, London, England. Explanation
35 FENPYROXIMATE (addendum) First draft prepared by T.C. Marrs Food Standards Agency, London, England Explanation... 35 Evaluation for an acute reference dose... 35 Toxicological studies... 35 Short-term
More informationCommittee for Risk Assessment RAC. Annex 3. Records. of the targeted experts consultations November 2012 on. Cycloxydim
Committee for Risk Assessment RAC Annex 3 Records of the targeted experts consultations 5-19 November 2012 on Cycloxydim EC number: 405-230-9 CAS number: 101205-02-1 ECHA/RAC/CLH-O-0000003157-76-01/A3
More informationFurther Observations on the Teratogenic Action of the Thyroid Stimulating Hormone '
Further Observations on the Teratogenic Action of the Thyroid Stimulating Hormone ' ALLAN R. BEAUDOIN Department of Anatomy, The University of Michigan, Ann Arbor, Michigan ABSTRACT Pregnant Wistar Albino
More informationAuswertung visceraler Anomalien:
Auswertung visceraler Anomalien: General 10125 Aneurysm 15 2 2 1 20 68,42 10126 Fluid-filled abdomen 4 11 5 0 20-35,00 10127 Situs inversus 18 2 0 0 20 80,00 Brain 10128 Dilated cerebral ventricle 11 7
More informationContents: Volume 1 of 2 Text, Summary Tables, and Appendices A-F
FINAL REPORT Contents: Volume 1 of 2 Text, Summary Tables, and Appendices A-F Study Title: Study Number: An Oral (Gavage) 14-Day and Pilot Prenatal Developmental Toxicity Study of Naphthenic Acid in Rats
More information5.15 HEXYTHIAZOX (176)
Hexythiazox 225 5.15 HEXYTHIAZOX (176) TOXICOLOGY Hexythiazox is the ISO approved name for (trans-5-(4-chlorophenyl)-n-cyclohexyl-4-methyl-2-oxo- 3-thiazolidine-carboxamide (CAS No. 78587-05-0). Hexythiazox
More informationIMAZALIL (addendum) First draft prepared by U. Mueller 1 and Roland Solecki 2. Federal Institute for Risk Assessment, Berlin, Germany
303 IMAZALIL (addendum) First draft prepared by U. Mueller 1 and Roland Solecki 2 1 Office of Chemical Safety,Therapeutic Goods Administration, Canberra ACT, Australia; and 2 Safety of Substances and Preparations
More informationLongitudinal study to follow-up a developmental abnormality Luc De Schaepdrijver, DVM, PhD Preclinical Development & Safety Janssen R&D, Belgium
Longitudinal study to follow-up a developmental abnormality Luc De Schaepdrijver, DVM, PhD Janssen R&D, Belgium ILSI-HESI Workshop, Washington, April 21 st, 2015 Fetal Imaging in Regulatory Developmental
More informationObstetrics Content Outline Obstetrics - Fetal Abnormalities
Obstetrics Content Outline Obstetrics - Fetal Abnormalities Effective February 2007 10 16% renal agenesis complete absence of the kidneys occurs when ureteric buds fail to develop Or degenerate before
More information5.24 TRIAZOLE FUNGICIDE METABOLITES
Triazole metabolites 355 5.24 TRIAZOLE FUNGICIDE METABOLITES TOXICOLOGY 1,2,4-Triazole, triazole alanine, triazole acetic acid, triazole pyruvic acid and triazole lactic acid are the common metabolites
More informationSummary of Inhalation Carcinogenicity Study. of Isopropyl Acetate. in F344 Rats
Summary of Inhalation Carcinogenicity Study of Isopropyl Acetate in F344 Rats March 2009 Japan Bioassay Research Center Japan Industrial Safety and Health Association PREFACE The tests were contracted
More informationDIETARY RISK ASSESSMENT
194 Folpet On the fat basis, the Meeting estimated a maximum residue level of 0.2 mg/kg for poultry meat (fat), an STMR value of 0.05 mg/kg and an HR value of 0.13 mg/kg. Based on the liver results, the
More informationCommittee for Risk Assessment RAC. Annex 5. to the RAC Opinion on toxicity to reproduction of. Epoxiconazole
Committee for Risk Assessment RAC Annex 5 to the RAC Opinion on toxicity to reproduction of Epoxiconazole ECHA/RAC/A77-O-0000001412-86-08/A5 Adopted 28 November 2012 ANNEX 5 COMMENTS AND RESPONSE TO COMMENTS
More informationHeart and Lungs. LUNG Coronal section demonstrates relationship of pulmonary parenchyma to heart and chest wall.
Heart and Lungs Normal Sonographic Anatomy THORAX Axial and coronal sections demonstrate integrity of thorax, fetal breathing movements, and overall size and shape. LUNG Coronal section demonstrates relationship
More informationCycloxydim CYCLOXYDIM (179)
Cycloxydim 125 5.9 CYCLOXYDIM (179) TOXICOLOGY Cycloxydim is the ISO approved name for (5RS)-2-[(EZ)-1-(ethoxyimino)butyl]-3-hydroxy-5-[(3RS)- thian-3-yl]cyclohex-2-en-1-one (IUPAC). The CAS chemical name
More informationEmbryonic malformations in rats, resulting from maternal diabetes: preliminary observations
/. Embryol. exp. Morph. Vol. 41, pp. 93-99, 1977 93 Printed in Great Britain Company of Biologists Limited 1977 Embryonic malformations in rats, resulting from maternal diabetes: preliminary observations
More informationDithianon DITHIANON (180)
Dithianon 201 5.11 DITHIANON (180) TOXICOLOGY Dithianon (C 14 H 4 N 2 O 2 S 2 ) is the International Organization for Standardization (ISO) approved name for 5,10-dihydro-5,10-dioxonaphtho[2,3-b]-1,4-dithiine-2,3-dicarbonitrile
More informationThe development of asymmetry: the sidedness of drug-induced limb abnormalities is reversed in situs inversus mice
Development 7, 67-6 (989) Printed in Great Britain The Company of Biologists Limited 989 67 The development of asymmetry: the sidedness of drug-induced limb abnormalities is reversed in situs inversus
More informationDevelopmental Toxicity Study in Rats and Rabbits Administered an Emulsion Containing Medium Chain Triglycerides as an Alternative Caloric Source
FUDAMETAL AD APPUHD TOXICOLOGY 4, 1 8 5-1 9 (1 9 9 7) ARTICLE O FA972378 Developmental Toxicity Study in Rats and Rabbits Administered an Emulsion Containing Medium Chain Triglycerides as an Alternative
More informationCLH REPORT FOR 2-METHYL-1-(4-METHYLTHIOPHENYL)-2-MORPHOLINOPROPAN-1- ONE. CLH report. Proposal for Harmonised Classification and Labelling
CLH report Proposal for Harmonised Classification and Labelling Based on Regulation (EC) No 1272/2008 (CLP Regulation), Annex VI, Part 2 Substance Name: 2-methyl-1-(4-methylthiophenyl) -2- morpholinopropan-1-one
More informationAN ACUTE ORAL TOXICITY STUDY IN RATS WITH ADVANTRA Z
AN ACUTE ORAL TOXICITY STUDY IN RATS WITH ADVANTRA Z AMENDED FINAL REPORT Author Deborah A Douds, M.S. Original Study Completion Date July 8, 1997 Amended Study Completion Date November 19, 1997 Performing
More informationPrenatal hypoxia causes long-term alterations in vascular endothelin-1 function in aged male but not female offspring
1 2 3 4 5 6 7 8 9 1 11 12 13 14 Supplementary information for: Prenatal hypoxia causes long-term alterations in vascular endothelin-1 function in aged male but not female offspring Stephane L Bourque,
More informationAssessment of Reproductive Toxicity under REACH July Walter Aulmann
Assessment of Reproductive Toxicity under REACH July 2012 Walter Aulmann Position Paper Aulmann (2012), Assessment of reproductive toxicity under REACH. Regul. Toxicol. Pharmacol. 63 (2012) 286-290 Toxic
More informationAnnex I to the CLH report
Annex I to the CLH report Proposal for Harmonised Classification and Labelling Based on Regulation (EC) No 1272/2008 (CLP Regulation), Annex VI, Part 2 International Chemical Identification: 3-methylpyrazole
More informationSubstance Evaluation Conclusion document EC No SUBSTANCE EVALUATION CONCLUSION DOCUMENT. as required by REACH Article 48. for.
SUBSTANCE EVALUATION CONCLUSION DOCUMENT as required by REACH Article 48 for Methanol EC No 200-659-6 CAS No 67-56-1 Evaluating Member State(s): Poland Dated: 17/09/2015 Evaluating Member State Competent
More informationCHLOROPICRIN VAPOR EXPOSURE RESULTING FROM TREATED FIELD VAPOR
EMERGENCY MEDICAL TREATMENT GUIDE CHLOROPICRIN VAPOR EXPOSURE RESULTING FROM TREATED FIELD VAPOR SYNONYMS: Chloropicrin, Trichloronitromethane, Nitrochloroform (label names such as Tri- Clor and Tri-Pic).
More informationANATOMY & PHYSIOLOGY I Laboratory Version B Name Section. REVIEW SHEET Exercise 10 Axial Skeleton
ANATOMY & PHYSIOLOGY I Laboratory Version B Name Section REVIEW SHEET Exercise 10 Axial Skeleton 1 POINT EACH. THE SKULL MULTIPLE CHOICE 1. The major components of the axial skeleton include the 7. The
More informationAbstract. Introduction. RBMOnline - Vol 19. No Reproductive BioMedicine Online; on web 12 October 2009
RBMOnline - Vol 19. No 6. 2009 852 858 Reproductive BioMedicine Online; www.rbmonline.com/article/3726 on web 12 October 2009 Article Effect of exercise on the reproductive outcome and fetal development
More information2. MATERIAL AND METHODS
OMIMA et al. (211) studied developmental toxicity in rats given amitraz during gestation. Phytonutrients are abundant in whole grains such as barley and oat which protect against cancer and heart diseases.
More informationConsiderations of maternal toxicity in classification. George Daston
Considerations of maternal toxicity in classification George Daston Overview Maternal toxicity: how much is too much? what do guidelines tell us? What is the scientific consensus? Using weight of evidence
More informationC ONSIDERABLE ATTENTION has been given to the antifertility effects of
Effects of Clomiphene at Different Stages of Pregnancy in the Rat Implications Regarding Possible Action Mechanisms 0. W. DAVIDSON, M.D.,"' K. WADA, M.D.,t and S. J. SEGAL, Ph.D. C ONSIDERABLE ATTENTION
More informationCaptan (Pesticides) Summary. Risk assessment report. Food Safety Commission of Japan. Conclusion in Brief
2017 Food Safety Commission, Cabinet Office, Government of Japan doi: 10.14252/foodsafetyfscj.2017003s Food Safety 2017; Vol. 5, No. 2, 61 66 Risk assessment report Captan (Pesticides) Summary Food Safety
More informationAntimicrobial AlphaSan Test Report Summary Table 08/21/01
AlphaSan RC 5000 Physical Chemical Properties Acute Oral Toxicity, Rat EPA FIFRA 81-1 Acute Dermal Toxicity, Rat EPA FIFRA 81-2 Primary Dermal Irritation Rabbit EPA FIFRA 81-5 Primary Eye Irritation Rabbit
More informationSexual differentiation:
Abnormal Development of Female Genitalia Dr. Maryam Fetal development of gonads, external genitalia, Mullerian ducts and Wolffian ducts can be disrupted at a variety of points, leading to a wide range
More informationCommittee for Risk Assessment RAC. Opinion proposing harmonised classification and labelling at EU level on toxicity to reproduction of Epoxiconazole
Committee for Risk Assessment RAC Opinion proposing harmonised classification and labelling at EU level on toxicity to reproduction of Epoxiconazole EC number: 406-850-2 CAS number: 133855-98-8 ECHA/RAC/A77-O-0000001412-86-08/F
More informationULTRASOUND OF THE FETAL HEART
ULTRASOUND OF THE FETAL HEART Cameron A. Manbeian, MD Disclosure Statement Today s faculty: Cameron Manbeian, MD does not have any relevant financial relationships with commercial interests or affiliations
More informationMethod Version: GreenScreen Version 1.2. Verified or Non-Verified: VERIFIED
LLC and Clean Production Action Method Version: GreenScreen Version 1.2 Verified or Non-Verified: VERIFIED Date of Verification: November 15 2013 Expiration Date: November 15 2016 Uses: Restrictions: GreenScreen
More informationDr.ALI AL BAZZAZ PLASTIC SURGON CLEFT LIP AND PALATE
Dr.ALI AL BAZZAZ PLASTIC SURGON CLEFT LIP AND PALATE Cleft lip (cheiloschisis) and cleft palate (palatoschisis), which can also occur together as cleft lip and palate, are variations of a type of clefting
More informationResidual Solvents in medical cannabis analysis using the SRI 8610C FID GC Jan 2017
The SRI Medical Herb Potency 8610C GC is shown at right. This GC can also be used to test for residual solvents (i.e. butane, acetone, gasoline residue, etc.) in medical cannabis. These solvents are used
More informationThe Skeletal System. Parts of the skeletal system. Bones (Skeleton) Joints Cartilages Ligaments
The Skeletal System Parts of the skeletal system Bones (Skeleton) Joints Cartilages Ligaments Functions of the Bones Support Internal framework of the body Protection Skull and vertebrae protect brain
More informationISUOG Basic Training Distinguishing Between Normal and Abnormal Appearances of the Fetal Anatomy
ISUOG Basic Training Distinguishing Between Normal and Abnormal Appearances of the Fetal Anatomy Reem S. Abu-Rustum, Lebanon Learning Objective At the end of the lecture you will be able to: Compare the
More informationAPPENDIX A. ATSDR MINIMAL RISK LEVELS AND WORKSHEETS
A-1 APPENDIX A. ATSDR MINIMAL RISK LEVELS AND WORKSHEETS The Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA) [42 U.S.C. 9601 et seq.], as amended by the Superfund Amendments
More informationCARBENDAZIM (addendum)
87 CARBENDAZIM (addendum) First draft prepared by Rudolf Pfeil 1 and Vicki Dellarco 2 1 Federal Institute for Risk Assessment, Berlin, Germany; and 2 United States Environmental Protection Agency, Office
More informationUltrasound Anomaly Details
Appendix 2. Association of Copy Number Variants With Specific Ultrasonographically Detected Fetal Anomalies Ultrasound Anomaly Details Abdominal wall Bladder exstrophy Body-stalk anomaly Cloacal exstrophy
More informationISUOG Basic Training Distinguishing Between Normal and Abnormal Appearances of the Fetal Anatomy. Basic Training
ISUOG Distinguishing Between Normal and Abnormal Appearances of the Fetal Anatomy Learning Objective At the end of the lecture you will be able to: Compare the differences between the ultrasound appearances
More informationThe Musculoskeletal System
The Musculoskeletal System Introduction The skeletal system and muscular system are often considered together because they are close in terms of structure and function. The two systems are referred to
More informationPage 1132
Page 1131 Page 1132 Page 1133 Page 1134 Page 1135 Huntingdon Life Sciences 03-6140 Page 6. Final Report TABLE OF CONTENTS Page 1136 COVER PAGE...1 GLP STATEMENT...2 SIGNATURE PAGE...3 QUALITY ASSURANCE
More informationEPA Health Advisory for PFOA and PFOS Drinking Water
EPA Health Advisory for PFOA and PFOS Drinking Water David Klein, Ph.D Postdoctoral Fellow Pathology and Laboratory Medicine Brown University David_Klein@brown.edu Outline PFOA Background How did the advisory
More informationCentral nervous system. Obstetrics Content Outline Obstetrics - Fetal Abnormalities
Obstetrics Content Outline Obstetrics - Fetal Abnormalities Many congenital malformations of the CNS result from incomplete closure of the neural tube Effective February 2007 10 16% the most common neural
More informationSummary of Toxicity Studies on Imazapyr
Summary of Toxicity Studies on Imazapyr Technical Department, Cyanamid (Japan) Ltd. (Received July 15, 1997 ; Accepted August 20, 1997) DESCRIPTIO OF THE TEST COMPOUD Imazapyr is a nonselective herbicide
More information(Z)-1-Chloro-2,3,3,3-tetrafluoropropene (2017)
WORKPLACE ENVIRONMENTAL EXPOSURE LEVEL (Z)-1-Chloro-2,3,3,3-tetrafluoropropene (2017) I. IDENTIFICATION Chemical Name: (Z)-1-Chloro-2,3,3,3-tetrafluoropropene Synonyms: HCFO-1224yd(Z) CAS Number: 111512-60-8
More informationExercise 10. The Axial Skeleton
Exercise 10 The Axial Skeleton The Axial Skeleton Consists of the skeletal structures found along the midline of the body. Includes the skull, hyoid, vertebrae, ribs, sternum, and sacrum. The cartilages
More informationCongenital Anomalies
Congenital Anomalies Down Syndrome 7580 7580 DOWN''S SYNDROME Q900 Q90.0 : Trisomy 21, meiotic nondisjunction 7580 7580 DOWN''S SYNDROME Q901 Q90.1 : Trisomy 21, mosaicism (mitotic nondisjunction) 7580
More informationBENTAZONE (addendum) First draft prepared by T.C. Marrs Food Standards Agency, London, England
3 BENTAZONE (addendum) First draft prepared by T.C. Marrs Food Standards Agency, London, England Explanation... 3 Evaluation for acute reference dose... 3 Toxicological studies... 3 Short-term studies
More informationFree Amino Acid Changes in Serum throughout Rat Gestation and Lactation. Evolution of the Plasma/Serum Relationships
J. Clin. Biochem. Nutr., 3, 73-77, 1987 Free Amino Acid Changes in Serum throughout Rat Gestation and Lactation. Evolution of the Plasma/Serum Relationships M. PASTOR-ANGLADA, D. LOPEZ-TEJERO, and X. REMESAR*
More informationThiophanate-methyl -MATERIAL SAFETY DATA SHEET
Thiophanate-methyl -MATERIAL SAFETY DATA SHEET 1. Chemical Product Identification Product Name: Thiophanate-methyl Molecular Formula: C 12 H 14 N 4 O 4 S 2 Molecular Weight: 342.4 Structural Formula: Chemical
More informationAPPENDIX 6 EPIDEMOLOGY OF CORNELIA DE LANGE SYNDROME
APPENDIX 6 EPIDEMOLOGY OF CORNELIA DE LANGE SYNDROME Table 1. List of European registries contributing to the study: years of data, total number of births, prenatal diagnosis policy, followup of cases
More informationModule: Foundation Principles of Life Science for Midwifery Practice. WHH1008-N
Module: Foundation Principles of Life Science for Midwifery Practice. WHH1008-N 2015 Welcome to the Anatomy Workbook. This directed learning has been developed to prepare you for lectures designed to study
More informationA. Incorrect! The axial skeleton includes bones of the skull, inner ear, chest and spinal column.
Anatomy and Physiology - Problem Drill 07: The Skeletal System II No. 1 of 10 1. Which of the following statements about the axial skeleton is correct? A. The axial skeleton includes bones of the skull,
More informationSURGICAL PROCEDURE DESCRIPTIONS
SURGICAL PROCEDURE DESCRIPTIONS GONADECTOMY: CASTRATION USING SCROTAL METHOD 1. The animal is anesthetized and placed in dorsal recumbency with the tail toward the surgeon. 2. The abdominal and scrotal
More informationSummary of Toxicological Studies on Acrinathrin
Summary of Toxicological Studies on Acrinathrin Market Development, AgrEvo Japan Limited (Received January 26, 1998 ; Accepted March 20, 1998) DESCRIPTION OF THE TEST CHEMICALS Acrinathrin is a new active
More informationChapter 7. Skeletal System
Chapter 7 Skeletal System 1 Skull A. The skull is made up of 22 bones: 8 cranial bones, 13 facial bones, and the mandible. B. The Cranium encloses and protects the brain, provides attachments for muscles,
More informationCOMMITTEE FOR VETERINARY MEDICINAL PRODUCTS
European Medicines Agency Veterinary Medicines and Inspections EMEA/MRL/615/99-FINAL Rev.1 1 May 2008 COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS 1-METHYL-2-PYRROLIDONE SUMMARY REPORT (2) 1. 1-Methyl-2-pyrrolidone
More informationThe Fetal Cardiology Program
The Fetal Cardiology Program at Texas Children s Fetal Center About the program Since the 1980s, Texas Children s Fetal Cardiology Program has provided comprehensive fetal cardiac care to expecting families
More informationSupplementary Online Content
Supplementary Online Content Honein MA, Dawson AL, Petersen E, et al; US Zika Pregnancy Registry Collaboration. Birth Defects Among Fetuses and Infants of US Women With Laboratory Evidence of Possible
More informationInternational Journal of Biomedical Research. THORACIC ECTOPIA CORDIS - A CASE REPORT D. Madhavi* 1 and T.K Rajasree 2
International Journal of Biomedical Research THORACIC ECTOPIA CORDIS - A CASE REPORT D. Madhavi* 1 and T.K Rajasree 2 1 Assistant Prof., Department of Anatomy, Guntur Medical College, Guntur-522004, A.P,
More informationSummary of Inhalation Carcinogenicity Study. of Tetrachloroethylene. in BDF 1 Mice
Summary of Inhalation Carcinogenicity Study of Tetrachloroethylene in BDF 1 Mice March 1993 Japan Bioassay Laboratory Japan Industrial Safety and Health Association PREFACE The tests were contracted and
More informationGE Healthcare Life Sciences. Quality matters. Whatman TM filters for air monitoring
GE Healthcare Life Sciences Quality matters Whatman TM filters for air monitoring Quality matters Why does quality matter? Particulate testing Examples include PM 10 & PM 2.5 particulate monitoring. Quality
More information5.2 ATRAZINE TOXICOLOGY
. 5.2 ATRAZINE TOXICOLOGY Atrazine, 6-chloro-N 2 -ethyl-n 4 -isopropyl-1,3,5-triazine-2,4-diamine (International Union of Pure and Applied Chemistry, IUPAC) (CAS No. 1912-24-9), is a selective systemic
More informationSupplemental Information
ARTICLE Supplemental Information SUPPLEMENTAL TABLE 6 Mosaic and Partial Trisomies Thirty-eight VLBW infants were identified with T13, of whom 2 had mosaic T13. T18 was reported for 128 infants, of whom
More informationSkeletal system. Prof. Abdulameer Al-Nuaimi. E. mail:
Skeletal system Prof. Abdulameer Al-Nuaimi E-mail: a.al-nuaimi@sheffield.ac.uk E. mail: abdulameerh@yahoo.com Functions of Bone and The Skeletal System Support: The skeleton serves as the structural framework
More informationAge at Puberty and First Litter Size in Early and Late Paired Rats 2
BIOLOGY OF REPRODUCTION 34, 322-3 26 (1986) Age at Puberty and First Litter Size in Early and Late Paired Rats 2 ALIDA M. EVANS Cancer Prevention Program 1300 University Avenue-7C University of Wisconsin
More informationCORESTA RECOMMENDED METHOD N 8
CORESTA RECOMMENDED METHOD N 8 DETERMINATION OF WATER IN THE MAINSTREAM SMOKE OF CIGARETTES BY GAS CHROMATOGRAPHIC ANALYSIS (August 1991) 1. FIELD OF APPLICATION The method is applicable to the particulate
More informationCellular Toxicity of Phthalate Esters
Environmental Health Perspectives Teratogenicity, Mutagenicity, and Cellular Toxicity of Phthalate Esters by E.. Dillingham* and J. Autian* Growing concern that phthalic acid esters (PAE) may present a
More informationTRIFLURALIN (P.C. Code ) - Report of the Hazard Identification Assessment Review Committee.
UNITED STATES ENVIRONMENTAL PROTECTION AGENCY WASHINGTON, D.C. 20460 OFFICE OF PREVENTION, PESTICIDES AND TOXIC SUBSTANCES TXR No.: 0051869 DATE: May 2, 2003 MEMORANDUM SUBJECT: FROM: THROUGH: TO: TRIFLURALIN
More informationTwo Separated Protocols with the Most Important Comments for Skeletal Staining in Embryonic and Adulthood Period in Laboratory Animals
May 2014, Volume 11, Number 2 Two Separated Protocols with the Most Important Comments for Skeletal Staining in Embryonic and Adulthood Period in Laboratory Animals Farzane Sadeghi * PhD in Anatomical
More informationDISSECTION 8: URINARY AND REPRODUCTIVE SYSTEMS
8546d_c01_1-42 6/25/02 4:32 PM Page 38 mac48 Mac 48: 420_kec: 38 Cat Dissection DISSECTION 8: URINARY AND REPRODUCTIVE SYSTEMS Typically, the urinary and reproductive systems are studied together, because
More informationBIO 137 AXIAL SKELETON BONE STUDY THE HUMAN SKELETON
BIO 137 THE AXIAL SKELETON MARY CATHERINE FLATH, Ph.D. THE HUMAN SKELETON AXIAL SKULL HYOID THORACIC CAGE VERTEBRAL COLUMN APPENDICULAR PECTORAL GIRDLE UPPER LIMBS PELVIC GIRDLE LOWER LIMBS AXIAL SKELETON
More informationSIAM 31, October 2010 SIDS INITIAL ASSESSMENT PROFILE
SIDS INITIAL ASSESSMENT PROFILE CAS No. 137-26-8 Chemical Name Bis(dimethylthiocarbamoyl)disulfide; Thiram Structural Formula Physical and chemical properties SUMMARY CONCLUSIONS OF THE SIAR Bis(dimethylthiocarbamoyl)disulfide
More informationCOLLECTIVE EXPERT APPRAISAL: SUMMARY AND CONCLUSIONS
COLLECTIVE EXPERT APPRAISAL: SUMMARY AND CONCLUSIONS Related to the establishment of a Toxicity Reference Value based on the reprotoxic effects of nonylphenols AFSSET Only the French language version of
More information2.0 PHYSICAL/CHEMICAL PROPERTIES CHARACTERIZATION
1.0 EXECUTIVE SUMMARY CREOSOTE - TOXICOLOGY Creosote is a fungicide, insecticide, and sporicide used as a wood preservatives for above and below ground wood protection treatments as well as treating wood
More informationMONOGRAPHS (NF) Pharmacopeial Forum 616 HARMONIZATION Vol. 31(2) [Mar. Apr. 2005]
616 HARMONIZATION Vol. 31(2) [Mar. Apr. 2005] the recorder. The substances are eluted in the following order: o-toluenesulfonamide, p-toluenesulfonamide, and caffeine. The test is not valid unless the
More informationSmall Scale Preparative Isolation of Corticosteroid Degradation Products Using Mass-Based Fraction Collection Application
Small Scale Preparative Isolation of Corticosteroid Degradation Products Using Mass-Based Fraction Collection Application Pharmaceutical Author Cliff Woodward Agilent Technologies, Inc. 285 Centerville
More informationGrand Rounds Mullerian Anomalies. Sara Schaenzer, PGY-3 9/26/18
Grand Rounds Mullerian Anomalies Sara Schaenzer, PGY-3 9/26/18 Background Congenital uterine anomalies occur in 2-4% of women Three times more common in women with recurrent pregnancy loss True incidence
More informationDevelopment of Respiratory System. Dr. Sanaa Alshaarawy& Dr. Saeed Vohra
Development of Respiratory System Dr. Sanaa Alshaarawy& Dr. Saeed Vohra OBJECTIVES At the end of the lecture the students should be able to: Identify the development of the laryngeotracheal (respiratory)
More informationJournal of American Science 2017;13(5)
Journal of American Science 2017;13(5) Effects of Dietary Soybean Phytoestrogens Usage on the Skeleton of Albino Rats During In-Utero Development El-Nahla, S.M.M. 1 ; El-Mahdy, T.O.M. 1 ; Takahashi, S.
More informationValidation of Isovaleraldehyde Using SKC UMEx 100 Diffusive Samplers (Cat. No )
Validation of Isovaleraldehyde Using SKC UMEx 100 Diffusive Samplers (Cat. No. 500-100) Page 1 of 9 Publication 1874 Rev 1607 Research Report Validation of Isovaleraldehyde Using SKC UMEx 100 Diffusive
More informationThe Skeletal System. Chapter 7a. Skeletal System Introduction Functions of the skeleton Framework of bones The skeleton through life
The Skeletal System Skeletal System Introduction Functions of the skeleton Framework of bones The skeleton through life Chapter 7a Support Protection Movement Storage areas Minerals Lipids Hemopoiesis
More informationSHRIRAM INSTITUTE FOR INDUSTRIAL RESEARCH
IN RATS SUB CHRONIC ORAL TOXICITY WITH NHH 44 Bt-COTTON SEEDS Report for: UNIVERSITY OF AGRICULTURAL SCIENCES AGRICULTURAL RESEARCH STATION DHARWAD-580007 KARNATAKA Guidelines: DBT, Guidelines for Toxicity
More informationDANIEL R. DOERGE U.S. Food and Drug Administration National Center for Toxicological Research Jefferson, AR
Research support by Interagency Agreement between NTP/NIEHS and NCTR/FDA The opinions presented are not necessarily those of the U.S. FDA or NTP NCTR/FDA Research on BPA: Integrating pharmacokinetics in
More informationCV Anatomy Quiz. Dr Ella Kim Dr Pip Green
CV Anatomy Quiz Dr Ella Kim Dr Pip Green Q1 The location of the heart is correctly described as A) lateral to the lungs. B) medial to the sternum. C) superior to the diaphragm. D) posterior to the spinal
More informationTo: National Toxicology Program (NTP); Center for the Evaluation of Risks to Human Reproduction (CERHR)
February 2, 2007 To: National Toxicology Program (NTP); Center for the Evaluation of Risks to Human Reproduction (CERHR) From: Natural Resources Defense Council These comments are submitted by Natural
More informationExtended therapeutic validation of an anti-mc4 receptor antibody in an animal model of anorexia nervosa
Extended therapeutic validation of an anti-mc4 receptor antibody in an animal model of anorexia nervosa (project no. 04-12B) Authors Guus Akkermans, Martien Kas Preliminary data report Introduction In
More informationTHE HEART OBJECTIVES: LOCATION OF THE HEART IN THE THORACIC CAVITY CARDIOVASCULAR SYSTEM
BIOLOGY II CARDIOVASCULAR SYSTEM ACTIVITY #3 NAME DATE HOUR THE HEART OBJECTIVES: Describe the anatomy of the heart and identify and give the functions of all parts. (pp. 356 363) Trace the flow of blood
More informationThe Investigation of Factors Contributing to Immunosuppressant Drugs Response Variability in LC-MS/MS Analysis
The Investigation of Factors Contributing to Immunosuppressant Drugs Variability in LC-MS/MS Analysis Joseph Herman, Dayana Argoti, and Sarah Fair Thermo Fisher Scientific, Franklin, MA, USA Overview Purpose:
More informationChapter 7 The Skeletal System:The Axial Skeleton
Chapter 7 The Skeletal System:The Axial Skeleton Axial Skeleton 80 bones lie along longitudinal axis skull, hyoid, vertebrae, ribs, sternum, ear ossicles Appendicular Skeleton 126 bones upper & lower limbs
More informationNormal and Abnormal Development of the Genital Tract. Dr.Raghad Abdul-Halim
Normal and Abnormal Development of the Genital Tract Dr.Raghad Abdul-Halim objectives: Revision of embryology. Clinical presentation, investigations and clinical significance of most common developmental
More information